Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Biogen
Company Monitoring Page for Biogen
latest headlines for company on cafepharma
The Alzheimer's pipeline is as strong as ever. Now, we just need the patients
Fierce Biotech
Wed, 05/31/23 - 07:02 pm
Tags:
Alzheimer's disease
,
patients
,
clinical trials
,
Biogen
,
Eisai
,
Eli Lilly
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
Amyloid-Beta Structure Revelation Sheds Light on Leqembi’s Function
BioSpace
Wed, 05/24/23 - 06:51 pm
Tags:
Eisai
,
Biogen
,
Alzheimer's disease
,
Leqembi
,
amyloid beta
JAMA: Leqembi could cost Medicare up to $5B per year
Medical Marketing and Media
Mon, 05/15/23 - 06:20 pm
Tags:
Biogen
,
Eisai
,
Leqembi
,
drug pricing
,
Medicare
,
Alzheimer's disease
,
JAMA
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
Tags:
drug launches
,
AbbVie
,
Almirall
,
Apellis Pharmaceuticals
,
Astellas
,
AstraZeneca
,
Biogen
,
CRISPR Therapeutics
,
Daiichi Sankyo
,
Eli Lilly
,
Genmab
,
GSK
,
Iveric Bio
,
Pfizer
,
Roche
,
SAGE Therapeutics
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Vertex Pharmaceuticals
Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations
BioSpace
Fri, 05/5/23 - 12:09 pm
Tags:
Biogen
,
Novartis
,
Sanofi
,
earnings
,
R&D
Biogen chalks up a Tecfidera patent win in Europe after losing US protections
Fierce Pharma
Fri, 05/5/23 - 11:50 am
Tags:
Biogen
,
Tecfidera
,
multiple sclerosis
,
Europe
Biogen paid CEOs Viehbacher, Vounatsos $57M in 2022
Medical Marketing and Media
Mon, 05/1/23 - 10:08 pm
Tags:
Biogen
,
Pharma CEOs
,
executive compensation
Will Biogen’s Qalsody Be a Catalyst for Gene-Specific ALS Research?
BioSpace
Thu, 04/27/23 - 11:51 am
Tags:
Biogen
,
Qalsody
,
tofersen
,
ALS
,
drug development
,
R&D
Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
CNBC
Wed, 04/26/23 - 09:59 am
Tags:
Biogen
,
earnings
,
Pharma CEOs
,
Chris Viehbacher
,
Eli Lilly
,
Alzheimer's disease
,
Leqembi
,
donanemab
FDA approves Biogen and Ionis’ Tofersen for rare genetic form of ALS
Medical Marketing and Media
Tue, 04/25/23 - 10:20 pm
Tags:
Biogen
,
Ionis Pharmaceuticals
,
ALS
,
tofersen
,
FDA
Busy with 3 program launches this year, Biogen trims pipeline
Fierce Biotech
Tue, 04/25/23 - 11:40 am
Tags:
Biogen
,
stroke
,
gene therapy
,
ophthalmology
,
earnings
Finding the big spenders beyond big pharma
EP Vantage
Mon, 04/24/23 - 10:15 am
Tags:
R&D
,
Amgen
,
Bayer
,
Biogen
,
Gilead Sciences
,
Merck KGaA
,
Moderna Therapeutics
,
Novo Nordisk
,
Regeneron Pharmaceuticals
,
UCB
,
Vertex Pharmaceuticals
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D
,
AbbVie
,
Amgen
,
AstraZeneca
,
Bayer
,
Biogen
,
Bristol Myers Squibb
,
Eli Lilly
,
Gilead Sciences
,
GSK
,
JNJ
,
Merck
,
Merck KGaA
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
UCB
,
Vertex Pharmaceuticals
Biogen buys into Denali’s amyloid beta program
Pharmaphorum
Thu, 04/13/23 - 10:05 am
Tags:
Biogen
,
Denali Therapeutics
,
Alzheimer's disease
In Another Round of Cuts, Biogen Lays Off Unspecified Number of Employees
BioSpace
Mon, 04/10/23 - 12:00 pm
Tags:
Biogen
,
layoffs
5 FDA decisions to watch in the second quarter
BioPharma Dive
Mon, 04/3/23 - 11:06 pm
Tags:
FDA
,
Sarepta Therapeutics
,
Duchenne Muscular Dystrophy
,
Biogen
,
tofersen
,
ALS
,
Seres Therapeutics
,
C. difficile
,
Pfizer
,
GSK
,
vaccines
,
RSV
,
Regeneron
,
Eylea
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA
,
AbbVie
,
Alvotech
,
Ascendis Pharma
,
Astellas
,
AstraZeneca
,
Biogen
,
Daiichi Sankyo
,
Eli Lilly
,
Ferring Pharmaceuticals
,
Hugel
,
Innoviva
,
Ionis Pharmaceuticals
,
Lundbeck
,
Merck
,
Novo Nordisk
,
Otsuka
,
Pfizer
,
Roche Seagen
,
Seres Therapeutics
,
Takeda
,
UCB
,
Vertex Pharmaceuticals
Massachusetts judge dismisses lawsuit against Biogen over failed launch of Alzheimer's drug Aduhelm
Endpoints
Thu, 03/30/23 - 11:05 pm
Tags:
Massachusetts
,
Biogen
,
Aduhelm
,
legal
Biogen Successfully Targets Tau in Phase Ib Alzheimer's Study
BioSpace
Thu, 03/30/23 - 11:02 pm
Tags:
Biogen
,
Alzheimer's disease
,
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.